Holiday Greeting from MMP

‘It saves lives’: Skin Cancer Doctors Call for Medicare Funding for Melanoma Photography

Melanoma surveillance photography, including total body photography and digital dermoscopy are commonly known as mole mapping, and dermatologists say it is a vital tool for the early detection of melanoma.

Ipilimumab Effective in Adolescents With Advanced Melanoma

Ipilimumab (Yervoy) was associated with a 1-year overall survival (OS) rate of 75% in adolescent patients with stage III/IV unresectable malignant melanoma.

IMO-2125, Yervoy Combo is on Fast Track for Treating Refractory Metastatic Melanoma

The U.S. Food and Drug Administration (FDA) granted fast track status to Idera Pharmaceuticals‘ IMO-2125, in combination with Yervoy (ipilimumab), for the treatment of metastatic melanoma patients whose disease progressed after anti-PD-1 therapy.

Cancer in the News

Feature Articles

Mathematical Model Mimics Melanoma

Cancer cells’ ability to tolerate crowded conditions may be one key to understanding tumor growth and formation, according to a mathematical model that has been applied to cancer cell growth for the first time.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

‘I Could Not Leave My Baby’: Mother-of-two Diagnosed With ‘Incurable’ Melanoma at 22-weeks’ Pregnant is BEATING Cancer Years Later

Like any mother, Karine Tobin was looking forward to the birth of her child.

Read the full story

Posted in Melanoma In The News, Patient Stories

Combination Therapies Shrink Brain Metastases from Melanoma

Melanoma patients with brain metastases may benefit from two combination regimens used to treat patients who have metastatic melanoma but no brain metastases, according to the early results of ongoing multicenter clinical trials led by investigators from The University of Texas MD Anderson Cancer Center.

Read the full story

Posted in Melanoma In The News, Clinical Trials

UMMS Scientists Identify Gene Sssociated With Metastatic Melanoma

WORCESTER, MA – A study by Craig J. Ceol, PhD, assistant professor of molecular medicine at the University of Massachusetts Medical School, has revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic melanoma.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories